Research activities
From the molecular to the global, Sansom Institute researchers are
involved in a diverse range of research activities across a broad spectrum
of health and medical sciences.
The Institute is essentially a federation of three research areas:
- The quality use of medicines and pharmacy research sector aims to optimise the use of medicines in the community, linking policy to best practice. Research strengths include medicines policy, pharmacoepidemiology, practice-based research, implementation and evaluation of new practices, and complementary medicines.
- The molecular medicine sector includes research that harnesses molecular advances and the latest technology to drive future therapeutic and diagnostic innovation. Research strengths include microbiology, immunology, inherited diseases, chemistry, venoms research and early origins of adult health.
- The pharmaceutical science sector includes research encompassing all aspects of drug development, including drug delivery, pharmacokinetics, natural products and computational pharmacology.
Weaving through these sectors are a number of groups and centres with expertise in areas as diverse as genetic diseases, animal and plant research, autism and pharmacogenomics.